文献速递鼻科

Pentraxin 3在遗传性出血性毛细血管扩张症中升高并反映鼻出血严重程度

Pentraxin 3 level is elevated in hereditary hemorrhagic telangiectasia and reflects the severity of disease-associated epistaxis.
PubMed 文献 · Laryngoscope · 2018-10-17

结果显示PTX3是唯一显著高于对照且与鼻出血严重度评分及血红蛋白水平显著相关的因子,VEGF虽升高但未达显著且与鼻出血严重度无显著相关。

要点

  • PTX3在HHT患者中显著高于健康对照
  • PTX3与鼻出血严重度评分及血红蛋白水平显著相关
  • VEGF与HHT鼻出血严重度无显著相关

核心结论

  • PTX3至少部分反映血管炎症,可作为HHT相关鼻出血严重度的潜在生物标志物。
  • HHT患者血清VEGF水平与鼻出血严重度不相关。

研究设计与样本

  • 前瞻性、比较性、单中心研究。
  • 采用酶免疫分析法检测与内皮细胞活化相关的血管生成和炎症因子。
  • 鼻出血严重度采用Epistaxis Severity Score及鼻出血强度、频率和需输血评分评估。

主要发现

  • PTX3是唯一在HHT患者中显著高于对照的因子,并与鼻出血严重度分级及血红蛋白水平显著相关。
  • VEGF水平在HHT患者中高于对照但未达显著程度。
  • 未观察到VEGF水平与鼻出血分级之间的显著相关。
  • 内器官表现的存在与血管生成因子水平之间无显著相关。

临床怎么用

  • PTX3可作为评估HHT相关鼻出血严重度的潜在生物标志物参考。
  • VEGF不宜作为HHT鼻出血严重度的评估指标。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES/HYPOTHESIS: We aimed to investigate if vascular endothelial growth factor (VEGF) and other angiogenic and inflammatory factors correlated with the clinical presentation in hereditary hemorrhagic telangiectasia (HHT) patients, particularly in regard to the severity of epistaxis. STUDY DESIGN: Prospective, comparative, single-center study. METHODS: One hundred nine samples were collected from 75 HHT patients attending the ear, nose, and throat department at Oslo University Hospital from February 2012 to August 2013. For comparison, samples were collected from 16 healthy controls. Angiogenic and inflammatory factors related to endothelial cell activation were analyzed by enzyme immunoassays. The grade of epistaxis was evaluated using the Epistaxis Severity Score and epistaxis Intensity, Frequency, and Need for Blood Transfusion score at the day of blood sampling. The presence of internal organ manifestations in the HHT group was recorded. RESULTS: Pentraxin 3 (PTX3) was the only factor that was significantly higher in the HHT patients than the controls and showed significant correlation to the epistaxis severity grade and the hemoglobin level. The VEGF level was higher in the HHT patients compared to controls but not to a significant degree. In addition, a significant correlation of the level of VEGF and the grade of epistaxis could not be observed. Also, no significant correlations were observed between the presence of internal organ manifestations and the level of angiogenic factors. CONCLUSIONS: PTX3, at least partly reflecting vascular inflammation, can be a potential biomarker for the severity of HHT associated epistaxis. The serum level of VEGF was not correlated with the severity of epistaxis in the HHT patients. LEVEL OF EVIDENCE: 2 Laryngoscope, 129:E44-E49, 2019.

来源:Laryngoscope,查看原文。版权归原作者所有。

引用

  1. Steineger J, Ueland T, Aukrust P, et al. Pentraxin 3 level is elevated in hereditary hemorrhagic telangiectasia and reflects the severity of disease-associated epistaxis. Laryngoscope. 2018. PMID: 30329172. doi:10.1002/lary.27548

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。